Masimo (Masimo) EBITDA Margin %

: 10.82% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Masimo's EBITDA for the three months ended in Dec. 2023 was $59 Mil. Masimo's Revenue for the three months ended in Dec. 2023 was $549 Mil. Therefore, Masimo's EBITDA margin for the quarter that ended in Dec. 2023 was 10.82%.

Masimo EBITDA Margin % Historical Data

The historical data trend for Masimo's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Masimo Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

27.51

25.64

25.04

17.45

11.56

Masimo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBITDA Margin %																23.76	11.36	13.57	10.71	10.82

Competitive Comparison

For the Medical Devices subindustry, Masimo's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Masimo EBITDA Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Masimo's EBITDA Margin % falls into.

Masimo EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Masimo's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	236.7	/	2048.1
	=	11.56 %

Masimo's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	59.4	/	548.9
	=	10.82 %

Masimo (NAS:MASI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Masimo EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Masimo's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Masimo (Masimo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

MASI:Mexico 3M4:Germany 3M4:Germany

Address

52 Discovery, Irvine, CA, USA, 92618

Website

https://www.masimo.com

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Executives

Rolf A Classon	director	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey	other: Director by deputization	POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan	director	1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani	director, officer: CEO and Chairman of the Board	4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi	officer: SVP, Chief Accounting Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi	officer: COO, Consumer Division	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy	officer: President, Consumer	1 VIPER WAY, VISTA CA 92081
Adam Mikkelson	director	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy	officer: EVP BUS DEV	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young	officer: EVP & Chief Financial Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan	officer: EVP & GENERAL COUNSEL	40 PARKER, IRVINE CA 92618
Craig B Reynolds	director	1046 MIDDLEBROOK WAY, KENESAW GA 30144